课题基金 / 基金详情

MicroRNAs, cardiac function and cardiomyopathy

MicroRNAs, cardiac function and cardiomyopathy
MicroRNA、心脏功能和心肌病
批准号:
10559334
负责人:
Da-Zhi Wang
金额:
$1.22万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-05-21 至 2022-06-30

项目摘要

项目成果

Da-Zhi Wang的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Contact PD/PI: Wang, Da-Zhi Cardiovascular disease is the leading cause of death in United States. However, the molecular events that control heart development and cardiac function are not fully understood. MicroRNAs (miRNAs) are a class of small regulatory RNA molecules found in most organisms. Emerging evidence has established that miRNAs play important regulatory roles, mainly by degrading target messenger RNAs (mRNAs) and/or inhibiting translation of protein-coding mRNAs in a variety of biological processes, including cell proliferation, differentiation and survival. miRNAs are also implicated in many human diseases, including cardiovascular disease. The discovery of miRNAs and their potential biological functions in regulating gene expression opened a completely new field to investigate how miRNAs participate in “classical” gene expression pathways. To date, more than 2,000 miRNAs have been identified in humans; however, the molecular mechanisms and the in vivo functions of most miRNAs remain unknown. The overall goal of this study is to define the biological function and the molecular mechanisms of miRNAs in the heart. Our central hypothesis is that miRNAs are components of the molecular circuitry that controls cardiac gene expression and function. More specifically, we will test our hypothesis that the Trbp-miR-208a pathway regulates cardiac function is a context-dependent manner. We present three integrative aims to test our hypothesis: Aim #1. What is the function of Trbp in the heart under pathophysiological stresses? Aim #2. How is the specificity of Trbp function in the miRNA pathway defined in the heart? Aim #3. What is the role of miR-208a in the heart and how does it work? Our studies will provide important insights into the molecular mechanisms by which miRNAs control mammalian heart development, function and cardiac gene expression. The molecular strategies we uncover in these studies will help define the ontogenesis of heart failure with potential broader implications for understanding the pathophysiology of cardiac disease in humans. Project Summary/Abstract Page 6
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.omtn.2020.11.007
发表时间: 2021-03-05
期刊: Molecular therapy. Nucleic acids
影响因子: --
作者: [Yan H, Wang H, Zhu X, Huang J, Li Y, Zhou K, Hua Y, Yan F, Wang DZ, Luo Y]
通讯作者: Luo Y
DOI: 10.3390/cells10123527
发表时间: 2021-12-14
期刊: Cells
影响因子: 6
作者: [Freire PP, Cury SS, Lopes LO, Fernandez GJ, Liu J, de Moraes LN, de Oliveira G, Oliveira JS, de Moraes D, Cabral-Marques O, Dal-Pai-Silva M, Hu X, Wang DZ, Carvalho RF]
通讯作者: Carvalho RF
DOI: 10.33594/000000309
发表时间: 2020-12-01
期刊: Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology
影响因子: --
作者: [de Oliveira Silva, Tabatha, Lino, Caroline A, Diniz, Gabriela P]
通讯作者: Diniz, Gabriela P
lncRNA Function and Mechanisms during Cardiac Development and Disease
  • 批准号:
    10608600
  • 项目类别:
  • 资助金额:
    $55.98万
  • 财政年份:
    2023
  • 负责人:
    Da-Zhi Wang
  • 依托单位:
Function and Mechanism of the Intercalated Disc Protein XinB in Cardiomyocyte Proliferation and Cardiac Regeneration
  • 批准号:
    10681642
  • 项目类别:
  • 资助金额:
    $56.36万
  • 财政年份:
    2023
  • 负责人:
    Da-Zhi Wang
  • 依托单位:
Molecular Mechanisms of Dystrophic Cardiomyopathy
  • 批准号:
    10402873
  • 项目类别:
  • 资助金额:
    $50.32万
  • 财政年份:
    2019
  • 负责人:
    Da-Zhi Wang
  • 依托单位:
Molecular Mechanisms of Dystrophic Cardiomyopathy
  • 批准号:
    10538161
  • 项目类别:
  • 资助金额:
    $6.53万
  • 财政年份:
    2019
  • 负责人:
    Da-Zhi Wang
  • 依托单位:
国内基金
海外基金
哺乳动物新生期心肌细胞增殖及其调控机制研究
抑制 miR-21 (微小RNA-21) 过表达对心肌重构和心力衰竭改善和治疗作用的研究
  • 批准号:
    81070128
  • 项目类别:
    面上项目
  • 资助金额:
    32.0万元
  • 批准年份:
    2010
  • 负责人:
    张越
  • 依托单位:
缺血条件下SDF-1/CXCR4轴调控心脏干细胞归巢研究
TRPM7离子通道在心脏成纤维细胞中分子机制与功能研究
  • 批准号:
    30670837
  • 项目类别:
    面上项目
  • 资助金额:
    27.0万元
  • 批准年份:
    2006
  • 负责人:
    蒋建敏
  • 依托单位: